{
    "root": "f82a3c89-df7c-4e2a-aa95-d5614239c847",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Montelukast",
    "value": "20250306",
    "ingredients": [
        {
            "name": "MONTELUKAST SODIUM",
            "code": "U1O3J18SFL"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "Montelukast sodium tablets are a leukotriene receptor antagonist indicated for: • Prophylaxis and chronic treatment of asthma in patients 15 years of   age and older (1.1). • Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older (1.2). • Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 15 years of age and older, and perennial allergic rhinitis (PAR) in patients 15 years of age and older. Reserve use for patients who have an inadequate response or intolerance to alternative therapies (1.3).",
    "contraindications": "Administration (by indications): • Asthma (2.1): Once daily in the evening for patients 15 years and older. • Acute prevention of EIB (2.2): One tablet at least 2 hours before exercise for patients 15 years of age and older. • Seasonal allergic rhinitis (2.3): Once daily for patients 15 years and older. • Perennial allergic rhinitis (2.3): Once daily for patients 15 years and older. Dosage (by age) (2): • 15 years and older: one 10 mg tablet. Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4).",
    "warningsAndPrecautions": "Montelukast sodium tablets, USP 10 mg are beige, rounded square-shaped, film-coated tablets debossed with 'I' on one side and '114' on the other side. They are supplied as follows:\n                  Overbagged with 10 film-coated tablets per bag, NDC 55154-8075-0\n                     \n                     Storage                 \n                     \n                     Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture and light. Store in original container. When product container is subdivided, repackage into a well-closed, light-resistance container.",
    "adverseReactions": "• Hypersensitivity to any component of this product."
}